-transparent.png){kind=logo}
A prospective randomized study of 195 patients with endometrial cancer, who were treated by adjuvant hormone therapy, is reported. 100 patients received 100 mg medroxyprogesterone acetate alone, 95 a combination of medroxyprogesterone acetate and tamoxifen (2 x 10 mg). Our data show no statistical difference between the two groups.
Related Publications
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
July 1991,
Annals of oncology : official journal of the European Society for Medical Oncology,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
June 1984,
European journal of obstetrics, gynecology, and reproductive biology,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
March 2004,
Climacteric : the journal of the International Menopause Society,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
January 1985,
Neoplasma,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
June 1988,
Gynecologic oncology,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
August 1989,
Journal of surgical oncology,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
November 1994,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
November 1989,
Gan to kagaku ryoho. Cancer & chemotherapy,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
May 1998,
Australasian radiology,
N Vavra, and
H Salzer, and
P Sevelda, and
G Breitenecker, and
K Czerwenka, and
H Kucera
January 1992,
Bulletin du cancer,
